Extended Data Table 3 Neutralization in participants after the first dose of BNT162b2 vaccine against wild-type and B.1.1.7, B.1.351 and P.1 spike mutant PVs

From: Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

  1. *Mutually adjusted for other variables in the table.
Back to article page